Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Daniel Fife"'
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 3, Pp 347-351 (2022)
Abstract Early Post‐Marketing Phase Vigilance (EPPV) is a unique system that encourages reporting of serious adverse reactions for medications newly introduced to Japan. When a once‐monthly paliperidone palmitate formulation (PP1M) was introduced
Externí odkaz:
https://doaj.org/article/8184aec024654bffb7498b9995661440
Autor:
Daniel Fife, Erica A. Voss, Jill Hardin, Hany Rofael, Ira D. Solomon, Patrick B. Ryan, Paul Stang
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 3, Pp 385-392 (2021)
Abstract Aim To assess label compliance in prescription of medications approved for treatment of attention‐deficit/hyperactivity disorder (ADHD) in Japan at the time of this study: methylphenidate (MPH), atomoxetine, and guanfacine. Methods Retrosp
Externí odkaz:
https://doaj.org/article/caf00790df7a4feb824fbc939bfd121f
Autor:
Yiting Wang, Rupa Makadia, Christopher Knoll, Jill Hardin, Erica A. Voss, Daniel Fife, Kourtney Davis, Sheldon Sloan
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background There has been a more pronounced shift toward earlier, more aggressive therapies in Crohn’s disease than in ulcerative colitis (UC). The aim of this study was to describe the pre-biologic treatment and health care experience, in
Externí odkaz:
https://doaj.org/article/a3a0105825aa4386a157601080a66ee5
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Fluoroquinolones are used for conditions including sinusitis, bronchitis, and urinary tract infections. It has been suggested that exposure to fluoroquinolones for these conditions is associated with disability resulting from adve
Externí odkaz:
https://doaj.org/article/1f0f06798eff4aa08463aeaacf2b3ddb
Autor:
Ajit A. Londhe, Chantal E. Holy, James Weaver, Sergio Fonseca, Angelina Villasis-Keever, Daniel Fife
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Objective The risk of retinal detachment (RD) following exposure to fluoroquinolone (FQ) has been assessed in multiple studies, however, results have been mixed. This study was designed to estimate the risk of RD following exposure to FQ, other commo
Externí odkaz:
https://doaj.org/article/3186d9ace9704f1b96369e577fa45b07
Autor:
Gang Li, Daniel Fife, Grace Wang, John J. Sheehan, Robert Bodén, Lena Brandt, Philip Brenner, Johan Reutfors, Allitia DiBernardo
Publikováno v:
Annals of General Psychiatry, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background Treatment-resistant depression (TRD) may represent a substantial proportion of major depressive disorder (MDD); however, the risk of mortality in TRD is still incompletely assessed. Methods Data were obtained from Optum Clinformat
Externí odkaz:
https://doaj.org/article/7733eac477eb4472a213a5026de25ef7
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0255887 (2021)
ObjectiveRecent observational studies suggest increased aortic aneurysm or dissection (AAD) risk following fluoroquinolone (FQ) exposure but acknowledge potential for residual bias from unreported patient characteristics. The objective of our study i
Externí odkaz:
https://doaj.org/article/cae91176752845f19705ace4d67e8d9c
Publikováno v:
Heliyon, Vol 5, Iss 3, Pp e01198- (2019)
Externí odkaz:
https://doaj.org/article/2e05c577a2f94db98bd227da5c9e568d
Publikováno v:
Heliyon, Vol 4, Iss 7, Pp e00707- (2018)
Background: Health services databases provide population-based data that have been used to describe the epidemiology and costs of treatment resistant depression (TRD). This retrospective cohort study estimated TRD incidence and, via sensitivity analy
Externí odkaz:
https://doaj.org/article/ba4276c67b714bd1bfa6c514faf80343
Autor:
Daniel Fife, M Soledad Cepeda, Alan Baseman, Henry Richards, Peter Hu, H Lynn Starr, Anthony G Sena
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0193453 (2018)
Observational studies of switching from branded to generic formulations of the same drug substance often lack appropriate comparators for the subjects who switched. Three generic formulations were deemed equivalent to Concerta: an authorized generic
Externí odkaz:
https://doaj.org/article/76e15ce9d6ed4398b32413a2bdc006cc